POMDOCTOR Ltd (POM)
$0.64-14.67%Close
SELLCRISIS · day 6
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $4M
- Beta
- 2.28
- P/E (TTM)
- -1.17
- Short % float
- 16.51%
- Days to cover
- 1.1
- SI change
- +42.1%
- 1W
- -24.71%
- 1M
- -14.67%
- vs SPY 1W
- -23.73%
- vs SPY 1M
- -16.53%
Industry peers
FMP comparable companies · ranked by market cap
- ERASSELLErasca, Inc.$5.6BRECOVERYQ 3$16.03-0.54%
- INNVSELLInnovage Holding Corp.$1.2BCRISISQ 14$9.10+0.67%
- SIBNBUYSI-BONE, Inc.$859MBULLQ 5$19.37-1.07%
- PACBBUYPacific Biosciences of California, Inc.$724MCRISISQ 4$2.33-2.93%
- FLGTSELLFulgent Genetics, Inc.$617MRECOVERYQ 13$21.74-0.24%
- AQSTSELLAquestive Therapeutics, Inc.$600MRECOVERYQ -4$4.78-1.28%
- CTMXSELLCytomX Therapeutics, Inc.$559MCRISISQ 6$2.57-4.29%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on POM?
- LOPJLB’s latest quantitative signal on POMDOCTOR Ltd (POM) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is POM in?
- POMDOCTOR Ltd (POM) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does POMDOCTOR Ltd (POM) do?
- Pomdoctor Limited, operating through its various divisions, runs an e-commerce platform for the direct sale of pharmaceutical products to consumers. The company is actively developing an online healthcare services platform specifically designed for managing long-term illnesses within the Chinese market. Its primary emphasis is on chronic disease care and pharmaceutical provision, facilitating a…